Onyx Scientific Limited

03947634 · Active

Company details

Type
Private Limited Company
Incorporated
2000-03-14
Country of origin
United Kingdom

Accounts & filings

Accounts last filed
2025-03-31 · MEDIUM
Next accounts due
2026-12-31 in 204 days
Confirmation statement
last made up 2026-03-14 · next due 2027-03-28

View full filing history at Companies House →

Registered office

Units 97 & 98 Silverbriar
Sunderland Enterprise Park East
Sunderland
Tyne And Wear
Sr5 2tq

Peer comparison

Compared against 19 UK companies in SIC 21100 (Manufacture of basic pharmaceutical products) within the Medium bracket (£1M–£10M net assets).

See where this company ranks

Included with the £1 AI analysis unlock — one payment unlocks both for this company. Yours forever.

Based on this company's latest filed accounts (to Mar 2025) · Full accounts — profit & loss and balance sheet.

Unlock for £1

Compares this company to 19 UK peers in Medium bracket, by net assets, turnover, profitability, and more.

Financial health

Derived from the filed accounts to Mar 2025. Figures only — not advice.

See this company's financial health

£1 unlocks the liquidity & profitability ratios, risk signals, the AI analysis and peer comparison for this company. One payment, yours forever.

Based on this company's latest filed accounts (to Mar 2025) · Full accounts — profit & loss and balance sheet.

Unlock for £1

Ratios and signals derived from this company's filed Companies House figures only.

Accounts

Based on this company's latest filed accounts (to Mar 2025) · Full accounts — profit & loss and balance sheet.

Year ending Mar 2025Mar 2024Mar 2023Mar 2022
Profit & loss
Turnover
£10,933,919
↓22.0%
£14,012,859
↓2.4%
£14,359,103
 
 
Gross profit
£4,849,908
↓37.1%
£7,712,180
↑3.8%
£7,427,159
 
 
Operating profit
£-286,469
 
£2,513,426
↓7.2%
£2,708,852
 
 
Profit before tax
£-252,028
 
£2,516,995
↓7.1%
£2,708,122
 
 
Profit / loss
£-236,550
 
£1,602,736
↓30.4%
£2,302,254
 
 
Balance sheet
Fixed assets
£5,787,062
↓14.8%
£6,794,765
↓9.9%
£7,543,305
 
 
Current assets
£5,079,766
↓25.4%
£6,812,687
↑26.1%
£5,400,704
 
 
Cash
£2,471,515
↓31.3%
£3,595,183
↑131.4%
£1,553,641
 
 
Debtors
£2,357,725
↓21.8%
£3,015,834
↓13.5%
£3,484,503
 
 
Net current assets
£4,191,217
↓8.9%
£4,598,666
↑48.9%
£3,089,335
 
 
Net assets
£9,204,990
↓11.8%
£10,441,540
↑6.1%
£9,838,804
 
 
Equity
£9,204,990
↓11.8%
£10,441,540
↑6.1%
£9,838,804
↑22.4%
£8,036,550
 
Other
Average employees
118
↑1.7%
116
↑6.4%
109
 
 
Dividends paid
£1,000,000
→0.0%
£1,000,000
↑100.0%
£500,000
 
 

Source: filed iXBRL accounts at Companies House. P&L items are only published by medium and large companies; small companies file abridged or micro-entity accounts where the P&L is not public.

Industry (SIC codes)

21100 · Manufacture of basic pharmaceutical products

Officers (17)

People with significant control (1)

Mortgages & charges (7)

1 outstanding · 6 satisfied

Recent filings (15)

Showing the 15 most recent filings. View full filing history at Companies House.

Source: Companies House register